These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 3119245
21. Induction of papillomas with a high probability of conversion to malignancy. Hennings H, Shores R, Mitchell P, Spangler EF, Yuspa SH. Carcinogenesis; 1985 Nov; 6(11):1607-10. PubMed ID: 2414025 [Abstract] [Full Text] [Related]
22. The protein kinase C activator L-alpha-dioctanoylglycerol: a potent stage II mouse skin tumor promoter. Verma AK. Cancer Res; 1988 Apr 01; 48(7):1736-9. PubMed ID: 3127039 [Abstract] [Full Text] [Related]
23. Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses. Meeran SM, Vaid M, Punathil T, Katiyar SK. Carcinogenesis; 2009 Mar 01; 30(3):520-8. PubMed ID: 19158151 [Abstract] [Full Text] [Related]
24. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice. National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1995 May 01; 429():1-286. PubMed ID: 12616302 [Abstract] [Full Text] [Related]
25. Regression and progression characteristics of papillomas induced by chrysarobin in SENCAR mice. Battalora MS, Conti CJ, Aldaz CM, Slaga TJ, Johnston DA, DiGiovanni J. Carcinogenesis; 1996 May 01; 17(5):955-60. PubMed ID: 8640943 [Abstract] [Full Text] [Related]
26. Comparison of octahydromezerein and mezerein as protein kinase C activators and as mouse skin tumor promoters. Sharkey NA, Hennings H, Yuspa SH, Blumberg PM. Carcinogenesis; 1989 Oct 01; 10(10):1937-41. PubMed ID: 2507191 [Abstract] [Full Text] [Related]
27. 12-O-tetradecanoylphorbol-13-acetate-mediated systemic co-promotion in the murine skin multistage carcinogenesis protocol. Reiners JJ, Pavone A, Maldve R, Fischer SM. Carcinogenesis; 1993 Mar 01; 14(3):411-5. PubMed ID: 8453717 [Abstract] [Full Text] [Related]
28. S/RV Cri-ba, a hairless mouse strain sensitive to skin tumorigenesis by suboptimal doses of 7,12-dimethylbenz[a]anthracene, initiation-promotion and two stage promotion protocols. Bhisey RA, Veturkar PL. Cancer Lett; 1990 Jun 30; 52(1):63-9. PubMed ID: 2112980 [Abstract] [Full Text] [Related]
29. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols. Iversen OH. APMIS Suppl; 1994 Jun 30; 41():1-38. PubMed ID: 7946481 [Abstract] [Full Text] [Related]
30. Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice. Wei H, Bowen R, Zhang X, Lebwohl M. Carcinogenesis; 1998 Aug 30; 19(8):1509-14. PubMed ID: 9744550 [Abstract] [Full Text] [Related]
31. Characterization of the antitumor-promoting activity of camptothecin in SENCAR mouse skin. Gao XM, Perchellet EM, Davis AW, Newell SW, Hua DH, Perchellet JP. Carcinogenesis; 1996 May 30; 17(5):1141-8. PubMed ID: 8640925 [Abstract] [Full Text] [Related]
33. Modulation of the co-promoting activity of gamma interferon in SENCAR and C57BL/6 mouse skin by difluoromethylornithine and the scheduling and duration of interferon treatment. Reiners JJ, Pavone A, Rupp T, Cantu AR. Carcinogenesis; 1990 Jan 30; 11(1):129-37. PubMed ID: 2104781 [Abstract] [Full Text] [Related]
34. Effects of short-term exposure to the tumor promoter, 12-O-tetradecanoylphorbol-13-acetate on skin carcinogenesis in SENCAR mice. Diwan BA, Ward JM, Henneman J, Wenk ML. Cancer Lett; 1985 Mar 30; 26(2):177-84. PubMed ID: 3919937 [Abstract] [Full Text] [Related]